Regenerative medicine as a disruptive technology: implications for manufacturing & clinical adoption (2019)
Attributed to:
SynthSys-Mammalian: Edinburgh Mammalian Synthetic Biology Research Centre
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18609/cgti.2019.135
Publication URI: http://dx.doi.org/10.18609/cgti.2019.135
Type: Journal Article/Review
Parent Publication: Cell and Gene Therapy Insights
Issue: 10